Nitric Acid

Nitric Acid

SCHEMBL7780974

O=[N+]([O-])O.O=[N+]([O-])[O-].O=[N+]([O-])[O-].O=[N+]([O-])[O-].[Zr]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.80
CA5B Q9Y2D0 1/20 0.80
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
ALDH1A1 P00352 3/20 0.33
TSHR P16473 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
HPGD P15428 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL4800705 1.00
Nitric Acid SCHEMBL19348276 0.95 CA5A (0.73) CA5ACA5BMEN1KMT2AALDH1A1
Nitric Acid SCHEMBL7780977 0.95 CA5A (0.89) CA5ACA5BMEN1KMT2AALDH1A1
Nitric Acid SCHEMBL4800710 0.95
Nitric Acid SCHEMBL135901 0.95
Nitric Acid SCHEMBL3892988 0.90 CA5A (0.80) CA5ACA5BMEN1KMT2AALDH1A1
Nitric Acid SCHEMBL11526417 0.90 CA5A (0.80) CA5ACA5BMEN1KMT2AALDH1A1
Nitric Acid SCHEMBL3417219 0.90 CA5A (0.80) CA5ACA5BMEN1KMT2AALDH1A1
Nitric Acid SCHEMBL343773 0.90
Nitric Acid SCHEMBL21177660 0.90 CA5A (0.80) CA5ACA5BMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117276801-A Ionic liquid-resistant cellulose/inorganic ceramic diaphragm and preparation method and application thereof 西安铝电科技发展有限公司 2023-12-22 CN claimed
EP-0845505-B1 Spherical colour pigments, process for their preparation and their use DMC2 DEGUSSA METALS CATALYSTS (DE) 2001-10-04 EP claimed
US-6080232-A Spherical color pigments, process for their production and use thereof DEGUSSA AKTIENGESELLSCHAFT (DE) 2000-06-27 US claimed
US-6074754-A MEAN PARTICLE DIAMETER OF LESS THAN 10 MUM, ON THE BASIS OF AN OXIDIC OR SILICATE SUBSTRATE MATERIAL WITH NOBLE METAL DISTRIBUTED EXTREMELY FINELY ON AND/OR IN THE PARTICLES. PREFERRED PIGMENTS ARE PURPLE-COLORED DEGUSSA AKTIENGESELLSCHAFT (DE) 2000-06-13 US claimed
CN-117276801-A Ionic liquid-resistant cellulose/inorganic ceramic diaphragm and preparation method and application thereof 西安铝电科技发展有限公司 2023-12-22 CN disclosed
US-10005718-B2 Catalyst, and method for producing oxidation product SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-06-26 US disclosed
EP-2940004-B1 METHOD FOR PRODUCING OXIME SUMITOMO CHEMICAL CO (JP) 2017-09-13 EP disclosed
US-9656950-B2 Method for producing oxime SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-23 US disclosed
US-9533944-B2 Method for producing oxime SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-01-03 US disclosed
EP-3103551-A1 CATALYST, AND METHOD FOR MANUFACTURING OXIDATION PRODUCT Sumitomo Chemical Company Limited (JP) 2016-12-14 EP disclosed
US-20160347707-A1 CATALYST, AND METHOD FOR PRODUCING OXIDATION PRODUCT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-12-01 US disclosed
US-9334211-B2 Hydrocracking catalyst, method for producing same, and method for producing hydroxy compound using said catalyst UBE INDUSTRIES, LTD. (JP) 2016-05-10 US disclosed
EP-2940004-A1 METHOD FOR PRODUCING OXIME Sumitomo Chemical Company Limited (JP) 2015-11-04 EP disclosed
US-20140288335-A1 HYDROCRACKING CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING HYDROXY COMPOUND USING SAID CATALYST UBE INDUSTRIES, LTD. (JP) 2014-09-25 US disclosed
US-6074754-A MEAN PARTICLE DIAMETER OF LESS THAN 10 MUM, ON THE BASIS OF AN OXIDIC OR SILICATE SUBSTRATE MATERIAL WITH NOBLE METAL DISTRIBUTED EXTREMELY FINELY ON AND/OR IN THE PARTICLES. PREFERRED PIGMENTS ARE PURPLE-COLORED DEGUSSA AKTIENGESELLSCHAFT (DE) 2000-06-13 US disclosed
EP-0010843-B1 METHOD OF MAKING 5,6-DIHYDRO-2-METHYL-N-PHENYL-1,4-OXATHIIN-3-CARBOXAMIDE UNIROYAL LTD. (CA) 1983-11-09 EP disclosed
EP-0042182-A2 Method of making 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide UNIROYAL LTD. (CA) 1981-12-23 EP disclosed
US-4247707-A CATALYTIC LIQUID-PHASE OXIDATION OF 2-METHYL-N-PHENYL-1,3-OXATHIOLANE-2-ACETAMIDE; THEN CATALYTIC THERMAL RING EXPANSION UNIROYAL CHEMICAL CO./UNIROYAL CHEMICAL CLE. (CA) 1981-01-27 US disclosed
EP-0010843-A1 Method of making 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide UNIROYAL LTD. (CA) 1980-05-14 EP disclosed
US-4182716-A Method of making 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide UNIROYAL, LTD. (CA) 1980-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288335-A1 HYDROCRACKING CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING HYDROXY COMPOUND USING SAID CATALYST HAO2, HMOX1, HMOX2 CA5A 366/4885CA5B 267/4885MEN1 1451/4885
US-20160347707-A1 CATALYST, AND METHOD FOR PRODUCING OXIDATION PRODUCT PPOX, HAO2, SCO2 CA5A 145/4885CA5B 106/4885MEN1 2480/4885
US-10005718-B2 Catalyst, and method for producing oxidation product PPOX, HAO2, SCO2 CA5A 145/4885CA5B 106/4885MEN1 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.